Exact Imaging today announced results from its OPTIMUM clinical trial demonstrating the non-inferiority of its ExactVu™ micro ...

OMAHA, Neb., Nov. 18, 2025 /PRNewswire/ -- Bot Image, Inc., a leader in AI-powered diagnostic imaging, today announced that its flagship software, ProstatID (R), has achieved UKCA certification under ...

A landmark £42 million trial aimed at revolutionising prostate cancer screening has officially begun in the UK, with the first eligible men now invited to participate. Health Secretary Wes Streeting ...

A major prostate cancer screening trial aimed at finding the best way to detect the disease has been launched in the UK. The ...

Microultrasonography for prostate biopsy detected clinically significant cancer at rates comparable to MRI-guided approaches. Detection rates for clinically insignificant cancers did not differ among ...

A Yale-led study examines the potential environmental benefits of more carefully selecting patients for prostate biopsy in a way that can also spare low-yield and potentially harmful procedures. Yale ...

Global Prostate Cancer Diagnostics Market OverviewThe global prostate cancer diagnostics market is projected to grow at a CAGR of approximately 12% during the forecast period, driven by a combination ...

"The Prostate Cancer iPRS test elevates risk assessment in men's health," said Dr. Akash Kumar, co-founder of MyOme. "By integrating genome sequencing with clinical risk factors, we can more precisely ...

A multicenter clinical study in Austria has shown that a new, highly precise ultrasound approach can successfully target and ...

Certification opens the United Kingdom market for the first FDA-cleared AI platform for prostate MRI interpretation. OMAHA, Neb., Nov. 18, 2025 /PRNewswire/ -- Bot Image ...